BAYZF - Bayer to seek regulatory approval for menopause drug after third trial success
2024-03-19 06:19:29 ET
Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said Tuesday it would seek marketing approval for its experimental menopause treatment, elinzanetant, after the drug was shown to reduce the frequency of hot flashes associated with menopause in a third late-stage trial....
Bayer to seek regulatory approval for menopause drug after third trial success